17 August 2022

CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

On 26 July 2022, the CAA published the new Circular 22/15 setting out regulatory requirements for the composition and functioning of the Board of Directors of insurance and reinsurance undertakings in the Solvency II framework.

The Circular 22/15 replaces previous circulars of the CAA, adds important clarifications to the EIOPA guidelines and confirms a few existing requirements.

The Circular 22/15 applies to insurance and reinsurance undertakings supervised by the CAA, including holding companies at the head of a group under the supervision of the CAA, with the exception of (i) captive insurance undertakings; (ii) captive reinsurance undertakings and (iii) non-captive reinsurance undertakings with gross annual premiums of less than EUR 100 million.

This GSK Update provides an overview on the new requirements for the governance of insurance and reinsurance companies.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Andreas Heinzmann, LL.M.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M.

Local Partner

+352 271802-32

valerio.scollo@gsk-lux.com

© GSK Stockmann 2022